Bijoy Hans Limited , a company listed on both the Calcutta Stock Exchange (CSE) and BSE Limited, has announced its intention to voluntarily delist its equity shares from the CSE. This strategic decision was approved by the company's Board of Directors during a meeting held on September 26, 2025.

Key Points of the Delisting Decision

• The Board of Directors convened on September 26, 2025, from 11:30 AM to 2:30 PM to discuss and approve the delisting proposal.
• Bijoy Hans Limited will continue to maintain its listing on BSE Limited, which offers nationwide trading terminals.
• The delisting process is subject to necessary approvals under the Securities and Exchange Board of India (SEBI) (Delisting of Equity Shares) Regulations, 2021.
• No exit opportunity is required to be provided to the company's shareholders as part of this delisting process.

Implications for Shareholders

The decision to delist from the CSE while retaining the BSE listing suggests that Bijoy Hans Limited is streamlining its market presence. Shareholders should note that their ability to trade the company's shares will not be affected, as the BSE listing will be maintained.

Regulatory Compliance

The company has emphasized that the delisting process will adhere to the applicable provisions of the SEBI (Delisting of Equity Shares) Regulations, 2021. This regulatory framework ensures that the interests of all stakeholders are protected during the delisting process.

Company Information

Bijoy Hans Limited, with the Corporate Identification Number (CIN) L51909AS1985PLC002323, is headquartered at H.P. Brahmachari Road, Rehabari, Kamrup, Guwahati, Assam, India. The company's scrip code on BSE is 524723, and the scrip ID is BITHANS.

Investors and stakeholders can find more information about Bijoy Hans Limited on their website www.bijoyhans.net or contact the company at compliance@arvayahealth.com .

As the delisting process moves forward, shareholders and interested parties are advised to stay informed about any further announcements from the company regarding the necessary approvals and the timeline for the delisting from the Calcutta Stock Exchange.

Bijoy Hans Limited , a company listed on the Bombay Stock Exchange (BSE), has successfully obtained trading approval for 45,00,000 equity shares issued on a preferential basis to promoters. The BSE granted the approval on September 9, 2025, paving the way for these shares to be listed and traded on the exchange starting September 10, 2025.

Key Details of the Preferential Issue

Regulatory Compliance and Approval Process

The company, in compliance with Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations 2015, promptly informed the stock exchange about the trading approval. The BSE issued the approval under reference number LOD/PREF/SV/247/2025-2026.

Impact on Trading

With this approval, the newly issued shares will be available for trading on the BSE starting September 10, 2025. This addition of 45 lakh shares to the company's existing share capital is expected to enhance liquidity for Bijoy Hans Limited's stock in the market.

Company's Statement

Guinea Agrawal, Company Secretary & Compliance Officer of Bijoy Hans Limited, confirmed the receipt of the trading approval in an official communication to the BSE. The company emphasized its commitment to keeping shareholders and the market informed about significant developments.

This preferential issue to promoters indicates a strong show of confidence in the company's future prospects by its core stakeholders. Investors and market participants will be keenly watching how this development impacts the stock's performance and the company's growth trajectory in the coming days.